R59.0

Localized enlarged lymph nodes

## Clinical Overview of Localized Lymphadenopathy Localized lymphadenopathy (ICD-10 code R59.0) refers to the enlargement of one or more lymph nodes in a single anatomical region. Pathologically, lymph nodes function as specialized filters within the lymphatic system, housing lymphocytes and macrophages that respond to foreign antigens. Enlargement occurs via four primary mechanisms: follicular hyperplasia due to immune stimulation, paracortical expansion from viral triggers, sinus histiocytosis in response to malignancy or inflammation, and direct infiltration by neoplastic cells or inflammatory cells (suppuration). ### Pathophysiology and Anatomical Significance The clinical significance of localized node enlargement depends heavily on the anatomical site. For instance, supraclavicular lymphadenopathy (e.g., Virchow’s node) is highly suspicious for intra-abdominal or thoracic malignancy, whereas submandibular or cervical nodes are frequently reactive to upper respiratory or dental infections. Axillary lymphadenopathy may suggest pathology in the breast or upper extremity, while inguinal nodes are often reactive to lower extremity infections or sexually transmitted diseases. Unlike generalized lymphadenopathy, which typically indicates systemic conditions like HIV, sarcoidosis, or systemic lupus erythematosus, localized lymphadenopathy is more often indicative of a regional process. ### Clinical Presentation and Evaluation Diagnostic evaluation begins with a thorough physical examination, assessing the size (nodes >1 cm are generally considered significant), consistency (soft/rubbery vs. hard/fixed), and the presence of tenderness. Tenderness often indicates an acute inflammatory or infectious process, whereas painless, stony-hard, and fixed nodes are red flags for metastatic carcinoma. The 'MIAMI' mnemonic (Malignancy, Infection, Autoimmune, Miscellaneous, Iatrogenic) provides a framework for differential diagnosis. ### Diagnostic Criteria and Standard of Care Standard of care involves a tiered approach. Patients with small, soft, and mobile nodes may be observed for a period of 2 to 4 weeks. If nodes persist, enlarge, or are associated with 'B symptoms' (fever, night sweats, unexplained weight loss), further investigation is required. Laboratory tests typically include a complete blood count (CBC) with differential, ESR, and CRP. Imaging, such as high-resolution ultrasonography or CT, provides insight into the nodal architecture. If clinical suspicion for malignancy or granulomatous disease remains high, a tissue diagnosis is necessary. While fine-needle aspiration (FNA) is used for initial cytology, excisional biopsy remains the gold standard for preserving nodal architecture, which is critical for the definitive diagnosis of lymphoma.

Clinical Symptoms

  • Palpable lump in a single body region
  • Localized tenderness or pain
  • Skin erythema (redness) over the node
  • Warmth at the site of enlargement
  • Fluctuance (if abscessed)
  • Regional drainage signs (e.g., associated skin wound)
  • Limited range of motion in the neck or limb
  • Occasional low-grade fever

Common Causes

  • Local bacterial infection (e.g., Staphylococcus aureus, Streptococcus pyogenes)
  • Viral infections (e.g., Epstein-Barr virus, Cytomegalovirus)
  • Cat-scratch disease (Bartonella henselae)
  • Metastatic carcinoma (e.g., breast, lung, or head and neck cancer)
  • Lymphoma (Hodgkin or Non-Hodgkin)
  • Tuberculosis (scrofula)
  • Fungal infections (e.g., histoplasmosis)
  • Reaction to local trauma or skin injury

Documentation & Coding Tips

Distinguish between Localized and Generalized involvement.

Example: Patient presents with a 2.5cm firm, non-tender right supraclavicular lymph node, present for 4 weeks. No other palpable nodes in the cervical, axillary, or inguinal chains. R59.0 used for localized assessment. Billing focus: Anatomical specificity of the right supraclavicular region. Risk adjustment: Presence of 'B-symptoms' such as unexplained weight loss (>10% body mass) or night sweats noted to assess severity/malignancy risk.

Billing Focus: Anatomical site and laterality

Document nodal characteristics and mobility.

Example: Examination of the left axillary region reveals multiple enlarged nodes, the largest being 3cm, fixed and matted. Overlying skin is normal. R59.0. Billing focus: Laterality (left) and specific site (axilla). Risk adjustment: Fixed/matted characteristics increase the complexity of the MDM regarding potential malignancy (HCC considerations) vs. reactive lymphadenopathy.

Billing Focus: Specific site and lymph node characteristics

Clarify the presence or absence of inflammatory signs.

Example: Acute right inguinal lymphadenopathy, 2cm, tender, fluctuant with overlying erythema. No evidence of distal skin infection. R59.0 plus L04.3 for acute lymphadenitis. Billing focus: Identification of the localized site (inguinal). Risk adjustment: Differentiating acute infectious (acute lymphadenitis) from chronic/neoplastic causes.

Billing Focus: Association with inflammatory processes

Link lymphadenopathy to primary underlying conditions if known.

Example: Enlarged submandibular lymph node (localized) noted in the setting of chronic lymphocytic leukemia (CLL). R59.0 should not be primary if the cause is the known neoplasm; however, for diagnostic workup of a new site, document R59.0 alongside C91.10. Billing focus: Secondary diagnosis for localized symptoms. Risk adjustment: HCC 48 (Lymphoma and Other Hematologic Malignancies) for the underlying CLL.

Billing Focus: Relationship to primary diagnosis

Specify duration and progression over time.

Example: Persistent left cervical lymphadenopathy (Level II), 2cm, stable for 3 months. No response to a 10-day course of Cephalexin. R59.0. Billing focus: Episode of care (persistent/recurrent). Risk adjustment: Duration impacts the 'Amount and/or Complexity of Data to be Reviewed' within the MDM framework.

Billing Focus: Chronicity and treatment response

Relevant CPT Codes

Related Diagnoses

Hierarchy